![Doug Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Doug Wilson
Technik-/Wissenschafts-/F&E-Leiter bei
Ferghana Partners Group
Profil
Douglas John Wilson is currently the Director at Vaxxit SRL, Mainz Consulting Ltd., and the Chief Medical Officer at Ferghana Partners Group.
He previously served as Chairman at SeaDragon Ltd. from 2012 to 2015, Chairman at Adherium (NZ) Ltd., Non-Executive Chairman at Adherium Ltd., and Non-Independent Executive Director at Neuren Pharmaceuticals Ltd. from 2011 to 2012.
He also served as Non-Executive Director at PYC Therapeutics Ltd. from 2007 to 2016 and as Independent Non-Executive Director at Photonz Corp.
Ltd. from 2011 to 2013.
Additionally, he is currently serving as an Independent Non-Executive Director at AFT Pharmaceuticals Ltd. since 2012.
He previously worked as Senior Vice President-Medical & Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. He holds a doctorate degree from the University of London.
Aktive Positionen von Doug Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
Vaxxit SRL
 Vaxxit SRL BiotechnologyHealth Technology Develops a live recombinant vaccine for the treatment of oral herpes and genital herpes | Direktor/Vorstandsmitglied | - |
Mainz Consulting Ltd. | Direktor/Vorstandsmitglied | - |
Ferghana Partners Group
 Ferghana Partners Group Investment ManagersFinance Provides healthcare corporate finance advisory services | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Doug Wilson
| Unternehmen | Position | Ende |
|---|---|---|
| AFT PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 05.08.2022 |
| PYC THERAPEUTICS LIMITED | Vorsitzender | 08.10.2015 |
| SEADRAGON LIMITED | Vorsitzender | 04.05.2015 |
| ADHERIUM LIMITED | Vorsitzender | 01.09.2016 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Doug Wilson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Neuren Pharmaceuticals Ltd.
 Neuren Pharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Manufactures drugs for neurological disorders | Health Technology |
Ferghana Partners Group
Ferghana Partners Group Investment ManagersFinance Provides healthcare corporate finance advisory services | Finance |
SeaDragon Ltd.
 SeaDragon Ltd. Food: Specialty/CandyConsumer Non-Durables Engages in refining, blending and supplying omega fish oils | Consumer Non-Durables |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Adherium (NZ) Ltd.
 Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Develops digital health technologies that address sub-optimal medication use in chronic disease | Technology Services |
Photonz Corp. Ltd.
 Photonz Corp. Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid | Health Technology |
AFT Pharmaceuticals Ltd.
 AFT Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Adherium Ltd.
 Adherium Ltd. Medical SpecialtiesHealth Technology Develops and manufactures solutions for the pharmaceutical sector | Health Technology |
Vaxxit SRL
Vaxxit SRL BiotechnologyHealth Technology Develops a live recombinant vaccine for the treatment of oral herpes and genital herpes | Health Technology |
Mainz Consulting Ltd. |
